TCT 2021: Late-breaking Science Video Collection

Published: 09 November 2021

Views:
2036
Likes:
7

Views:
2036
Likes:
7
Share:

Now Playing
Part 2 | Session 11 of 11
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG
David Kandzari

Up Next

22m 43s

Part 1 | Session 1 What's Hot at TCT 2021: View from the Thoraxcenter Nicolas M Van Mieghem, Joost Daemen

22m 33s

Part 1 | Session 2 View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up Nicolas M Van Mieghem, Joost Daemen

10m 32s

Part 2 | Session 1 FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG William Fearon

4m 40s

Part 2 | Session 2 iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR Matthias Gotberg

8m 19s

Part 2 | Session 3 SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB Rafael Romaguera

7m 32s

Part 2 | Session 4 CHOICE-CLOSURE: Plug-based Vs Suture-based Large-bore Vascular Closure Mohamed Abdel-Wahab

7m 27s

Part 2 | Session 5 TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients Susheel Kodali

8m 8s

Part 2 | Session 6 SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB Bruno Scheller

3m 37s

Part 2 | Session 7 Intrepid TMVR: Results Show Improved NYHA Class at 30 Days

6m 43s

Part 2 | Session 8 12Mo Results Comparing PCB With SCB Show No Difference in Clinical Incidences Wan Azman Wan Ahmad

4m 44s

Part 2 | Session 9 RADIANCE-HTN Trio: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant Hypertension Ajay J Kirtane

4m 28s

Part 2 | Session 10 BIO-RESORT: 5Y Outcomes Eline H Ploumen

Average (ratings)

No ratings

Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise and insightful preview of the late-breaking science presented at TCT 2021.

Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

View from the Thoraxcenter: Preview of the Late-Breaking Trials

2 sessions
What's Hot at TCT 2021: View from the Thoraxcenter	Watch now
View from the Thoraxcenter: TCT 21 Late-breaking Science Wrap Up	Watch now

Part 2

Expert Interviews

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

11 sessions
FAME3: PCI Guided by FFR Didn't Meet Noninferiority for 1Y Outcomes Compared to CABG	Watch now
iFR-SWEDEHEART: No Difference in Outcome at 5-yrs of iFR vs FFR	Watch now
SUGAR: Amphilimus-eluting Stents VS Zotarolimus-eluting Stents in Patients With DB	Watch now
CHOICE-CLOSURE: Plug-based Vs Suture-based Large-bore Vascular Closure	Watch now
TRISCEND II: 6Mo Outcomes Show TR Reduction in Majority of Patients	Watch now
SCB Shows Similar Angiographic Outcomes to Paclitaxel DCB	Watch now
Intrepid TMVR: Results Show Improved NYHA Class at 30 Days	Watch now
12Mo Results Comparing PCB With SCB Show No Difference in Clinical Incidences	Watch now
RADIANCE-HTN Trio: 6Mo Outcomes of RDN Vs a Sham Procedure for Resistant Hypertension	Watch now
BIO-RESORT: 5Y Outcomes	Watch now
OPTIMUM Registry: PCI in Patients at Prohibitive Risk for CABG	Watch now

Faculty Biographies

David Kandzari

Director of Interventional Cardiology and Chief Scientific Officer

Dr David Kandzari obtained his undergraduate degree from Duke University School of Medicine then completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences.

Dr Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology. He has authored and coauthored more than 150 studies, book chapters and scientific reviews. Dr Kandzari is board certified in internal medicine and cardiovascular diseases and is certified by the Board of Interventional Cardiology. He specializes in interventional cardiology, peripheral arterial disease and cardiovascular medicine. His…

View full profile